Table of Contents Author Guidelines Submit a Manuscript
Journal of Lipids
Volume 2011, Article ID 189876, 9 pages
http://dx.doi.org/10.1155/2011/189876
Review Article

Very-Low-Density Lipoprotein: Complex Particles in Cardiac Energy Metabolism

1Department of Physiology, Development and Neuroscience, University of Cambridge, Downing Street, Cambridge CB2 3EG, UK
2Department of Physiology, Anatomy and Genetics, University of Oxford, Parks Road Oxford OX1 3PT, UK

Received 28 November 2010; Accepted 9 May 2011

Academic Editor: Akihiro Inazu

Copyright © 2011 You-Guo Niu and Rhys D. Evans. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. J. van der Vusse, J. F. C. Glatz, H. C. G. Stam, and R. S. Reneman, “Fatty acid homeostasis in the normoxic and ischemic heart,” Physiological Reviews, vol. 72, no. 4, pp. 881–940, 1992. View at Google Scholar · View at Scopus
  2. R. A. Davis, S. C. Engelhorn, S. H. Pangburn, D. B. Weinstein, and D. Steinberg, “Very low density lipoprotein synthesis and secretion by cultured rat hepatocytes,” Journal of Biological Chemistry, vol. 254, no. 6, pp. 2010–2016, 1979. View at Google Scholar · View at Scopus
  3. J. McEneny, M. J. O'Kane, K. W. Moles et al., “Very low density lipoprotein subfractions in type II diabetes mellitus: alterations in composition and susceptibility to oxidation,” Diabetologia, vol. 43, no. 4, pp. 485–493, 2000. View at Google Scholar · View at Scopus
  4. D. A. Blasiole, R. A. Davis, and A. D. Attie, “The physiological and molecular regulation of lipoprotein assembly and secretion,” Molecular BioSystems, vol. 3, no. 9, pp. 608–619, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. R. D. Evans and Y. Niu, “Hypolipidaemic effects of high-dose insulin therapy,” British Journal of Anaesthesia, vol. 100, no. 4, pp. 429–433, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. D. D. Belke, T. S. Larsen, G. D. Lopaschuk, and D. L. Severson, “Glucose and fatty acid metabolism in the isolated working mouse heart,” American Journal of Physiology, vol. 277, no. 4, part 2, pp. R1210–R1217, 1999. View at Google Scholar · View at Scopus
  7. G. D. Lopaschuk and R. L. Barr, “Measurements of fatty acid and carbohydrate metabolism in the isolated working rat heart,” Molecular and Cellular Biochemistry, vol. 172, no. 1-2, pp. 137–147, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. G. D. Lopaschuk, D. D. Belke, J. Gamble, T. Itoi, and B. O. Schonekess, “Regulation of fatty acid oxidation in the mammalian heart in health and disease,” Biochimica et Biophysica Acta, vol. 1213, no. 3, pp. 263–276, 1994. View at Publisher · View at Google Scholar · View at Scopus
  9. R. J. Bing, A. Siegel, I. Ungar, and M. Gilbert, “Metabolism of the human heart. II. Studies on fat, ketone and amino acid metabolism,” The American Journal of Medicine, vol. 16, no. 4, pp. 504–515, 1954. View at Google Scholar · View at Scopus
  10. D. Hauton, M. J. Bennett, and R. D. Evans, “Utilisation of triacylglycerol and non-esterified fatty acid by the working rat heart: myocardial lipid substrate preference,” Biochimica et Biophysica Acta, vol. 1533, no. 2, pp. 99–109, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. A. S. Augustus, Y. Kako, H. Yagyu, and I. J. Goldberg, “Routes of FA delivery to cardiac muscle: modulation of lipoprotein lipolysis alters uptake of TG-derived FA,” American Journal of Physiology, vol. 284, no. 2, pp. E331–E339, 2003. View at Google Scholar · View at Scopus
  12. F. B. Ballard, W. H. Danforth, S. Naegle, and R. J. Bing, “Myocardial metabolism of fatty acids,” The Journal of Clinical Investigation, vol. 39, pp. 717–723, 1960. View at Google Scholar · View at Scopus
  13. H. K. Delcher, M. Fried, and J. C. Shipp, “Metabolism of lipoprotein lipid in the isolated perfused rat heart,” Biochimica et Biophysica Acta, vol. 106, no. 1, pp. 10–18, 1965. View at Google Scholar · View at Scopus
  14. M. B. Enser, F. Kunz, J. Borensztajn, L. H. Opie, and D. S. Robinson, “Metabolism of triglyceride fatty acid by the perfused rat heart,” Biochemical Journal, vol. 104, no. 1, pp. 306–317, 1967. View at Google Scholar · View at Scopus
  15. M. J. Bennett, D. Hauton, D. G. Hole, and R. D. Evans, “Preparation of radiolabelled very-low-density lipoprotein in high yield by extended rat liver perfusion,” Biotechnology Letters, vol. 22, no. 4, pp. 301–306, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. Y.-G. Niu and R. D. Evans, “Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference,” American Journal of Physiology, vol. 295, no. 5, pp. E1106–E1116, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. M. J. Bennett, D. Hauton, D. G. Hole, and R. D. Evans, “Utilization of very low density lipoprotein by rat heart: the effect of endotoxin,” American Journal of Physiology, vol. 278, no. 5, pp. E802–E810, 2000. View at Google Scholar · View at Scopus
  18. Y. G. Niu, D. Hauton, and R. D. Evans, “Utilization of triacylglycerol-rich lipoproteins by the working rat heart: routes of uptake and metabolic fates,” Journal of Physiology, vol. 558, no. 1, pp. 225–237, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Pillutla, Y. C. Hwang, A. Augustus et al., “Perfusion of hearts with triglyceride-rich particles reproduces the metabolic abnormalities in lipotoxic cardiomyopathy,” American Journal of Physiology, vol. 288, no. 6, pp. E1229–E1235, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Mardy, D. D. Belke, and D. L. Severson, “Chylomicron metabolism by the isolated perfused mouse heart,” American Journal of Physiology, vol. 281, no. 2, pp. E357–E364, 2001. View at Google Scholar · View at Scopus
  21. B. Teusink, P. J. Voshol, V. E. H. Dahlmans et al., “Contribution of fatty acids released from lipolysis of plasma triglycerides to total plasma fatty acid flux and tissue-specific fatty acid uptake,” Diabetes, vol. 52, no. 3, pp. 614–620, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Augustus, H. Yagyu, G. Haemmerle et al., “Cardiac-specific knock-out of lipoprotein lipase alters plasma lipoprotein triglyceride metabolism and cardiac gene expression,” Journal of Biological Chemistry, vol. 279, no. 24, pp. 25050–25057, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. A. S. Augustus, J. Buchanan, T. S. Park et al., “Loss of lipoprotein lipase-derived fatty acids leads to increased cardiac glucose metabolism and heart dysfunction,” Journal of Biological Chemistry, vol. 281, no. 13, pp. 8716–8723, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. P. F. Hahn, “Abolishment of alimentary lipemia following injection of heparin,” Science, vol. 98, no. 2531, pp. 19–20, 1943. View at Google Scholar · View at Scopus
  25. T. Pulinilkunnil and B. Rodrigues, “Cardiac lipoprotein lipase: metabolic basis for diabetic heart disease,” Cardiovascular Research, vol. 69, no. 2, pp. 329–340, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Camps, M. Reina, M. Llobera, S. Vilaro, and T. Olivecrona, “Lipoprotein lipase: cellular origin and functional distribution,” American Journal of Physiology, vol. 258, no. 4, part 1, pp. C673–C681, 1990. View at Google Scholar · View at Scopus
  27. S. Levak-Frank, W. Hofmann, P. H. Weinstock et al., “Induced mutant mouse lines that express lipoprotein lipase in cardiac muscle, but not in skeletal muscle and adipose tissue, have normal plasma triglyceride and high-density lipoprotein-cholesterol levels,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 6, pp. 3165–3170, 1999. View at Google Scholar · View at Scopus
  28. H. Wang and R. H. Eckel, “Lipoprotein lipase: from gene to obesity,” American Journal of Physiology, vol. 297, no. 2, pp. E271–E288, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. J. E. A. Braun and D. L. Severson, “Regulation of the synthesis, processing and translocation of lipoprotein lipase,” Biochemical Journal, vol. 287, no. 2, pp. 337–347, 1992. View at Google Scholar · View at Scopus
  30. I. J. Goldberg, “Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis,” Journal of Lipid Research, vol. 37, no. 4, pp. 693–707, 1996. View at Google Scholar · View at Scopus
  31. M. Merkel, R. H. Eckel, and I. J. Goldberg, “Lipoprotein lipase: genetics, lipid uptake, and regulation,” Journal of Lipid Research, vol. 43, no. 12, pp. 1997–2006, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Cheng and D. Hauton, “Cold acclimation induces physiological cardiac hypertrophy and increases assimilation of triacylglycerol metabolism through lipoprotein lipase,” Biochimica et Biophysica Acta, vol. 1781, no. 10, pp. 618–626, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Yagyu, G. Chen, M. Yokoyama et al., “Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy,” Journal of Clinical Investigation, vol. 111, no. 3, pp. 419–426, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Pulinilkunnil, D. Qi, S. Ghosh et al., “Circulating triglyceride lipolysis facilitates lipoprotein lipase translocation from cardiomyocyte to myocardial endothelial lining,” Cardiovascular Research, vol. 59, no. 3, pp. 788–797, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. L. G. Anderson, R. Carroll, H. S. Ewart, A. Acharya, and D. L. Severson, “Fatty acids reduce heparin-releasable LPL activity in cultured cardiomyocytes from rat heart,” American Journal of Physiology, vol. 273, no. 4, part 1, pp. E759–E767, 1997. View at Google Scholar · View at Scopus
  36. S. Takahashi, J. Sakai, T. Fujino et al., “The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor,” Journal of Atherosclerosis & Thrombosis, vol. 11, no. 4, pp. 200–208, 2004. View at Google Scholar · View at Scopus
  37. S. Takahashi, J. Sakai, T. Fujino, I. Miyamori, and T. T. Yamamoto, “The very low density lipoprotein (VLDL) receptor—a peripheral lipoprotein receptor for remnant lipoproteins into fatty acid active tissues,” Molecular & Cellular Biochemistry, vol. 248, no. 1-2, pp. 121–127, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Takahashi, J. Suzuki, M. Kohno et al., “Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase,” Journal of Biological Chemistry, vol. 270, no. 26, pp. 15747–15754, 1995. View at Publisher · View at Google Scholar · View at Scopus
  39. O. Tiebel, K. Oka, K. Robinson et al., “Mouse very low-density lipoprotein receptor (VLDLR): gene structure, tissue-specific expression and dietary and developmental regulation,” Atherosclerosis, vol. 145, no. 2, pp. 239–251, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. M. L. Brown, M. P. Ramprasad, P. K. Umeda et al., “A macrophage receptor for apolipoprotein B48: cloning, expression, and atherosclerosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 13, pp. 7488–7493, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Takahashi, T. Ito, Y. Zenimaru et al., “Species differences of macrophage very low-density-lipoprotein (VLDL) receptor protein expression,” Biochemical & Biophysical Research Communications, vol. 407, no. 4, pp. 656–662, 2011. View at Publisher · View at Google Scholar
  42. S. Takahashi, Y. Kawarabayasi, T. Nakai, J. Sakai, and T. Yamamoto, “Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 19, pp. 9252–9256, 1992. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Kwok, A. Singh-Bist, V. Natu, and F. B. Kraemer, “Dietary regulation of the very low density lipoprotein receptor in mouse heart and fat,” Hormone & Metabolic Research, vol. 29, no. 10, pp. 524–529, 1997. View at Google Scholar · View at Scopus
  44. H. Masuzaki, H. Jingami, N. Matsuoka et al., “Regulation of very-low-density lipoprotein receptor in hypertrophic rat heart,” Circulation Research, vol. 78, no. 1, pp. 8–14, 1996. View at Google Scholar · View at Scopus
  45. G. D. Lopaschuk, J. R. Ussher, C. D. L. Folmes, J. S. Jaswal, and W. C. Stanley, “Myocardial fatty acid metabolism in health and disease,” Physiological Reviews, vol. 90, no. 1, pp. 207–258, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. M. F. Allard, “Energy substrate metabolism in cardiac hypertrophy,” Current Hypertension Reports, vol. 6, no. 6, pp. 430–435, 2004. View at Google Scholar · View at Scopus
  47. A. Kamataki, S. Takahashi, K. Masamura et al., “Remnant lipoprotein particles are taken up into myocardium through VLDL receptor—a possible mechanism for cardiac fatty acid metabolism,” Biochemical and Biophysical Research Communications, vol. 293, no. 3, pp. 1007–1013, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Zenimaru, S. Takahashi, M. Takahashi et al., “Glucose deprivation accelerates VLDL receptor-mediated TG-rich lipoprotein uptake by AMPK activation in skeletal muscle cells,” Biochemical and Biophysical Research Communications, vol. 368, no. 3, pp. 716–722, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. S. H. Gianturco, M. P. Ramprasad, R. Song, R. Li, M. L. Brown, and W. A. Bradley, “Apolipoprotein B-48 or its apolipoprotein B-100 equivalent mediates the binding of triglyceride-rich lipoproteins to their unique human monocyte- macrophage receptor,” Arteriosclerosis, Thrombosis & Vascular Biology, vol. 18, no. 6, pp. 968–976, 1998. View at Google Scholar · View at Scopus
  50. G. Haraguchi, Y. Kobayashi, M. L. Brown et al., “PPARα and PPARγ activators suppress the monocyte-macrophage apoB-48 receptor,” Journal of Lipid Research, vol. 44, no. 6, pp. 1224–1231, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. G. Haraguchi, Y. Kobayashi, M. L. Brown et al., “Erratum: PPARα and PPARγ activators suppress the monocyte-macrophage apoB-48 receptor,” Journal of Lipid Research, vol. 44, no. 9, p. 1808, 2003. View at Google Scholar · View at Scopus
  52. A. Niemeier, M. Gåfvels, J. Heeren, N. Meyer, B. Angelin, and U. Beisiegel, “VLDL receptor mediates the uptake of human chylomicron remnants in vitro,” Journal of Lipid Research, vol. 37, no. 8, pp. 1733–1742, 1996. View at Google Scholar · View at Scopus
  53. I. J. Goldberg, R. H. Eckel, and N. A. Abumrad, “Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways,” Journal of Lipid Research, vol. 50, supplement, pp. S86–S90, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. K. M. Argraves, F. D. Battey, C. D. MacCalman et al., “The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes,” Journal of Biological Chemistry, vol. 270, no. 44, pp. 26550–26557, 1995. View at Publisher · View at Google Scholar · View at Scopus
  55. H. Yagyu, E. P. Lutz, Y. Kako et al., “Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency,” Journal of Biological Chemistry, vol. 277, no. 12, pp. 10037–10043, 2002. View at Publisher · View at Google Scholar · View at Scopus
  56. W. C. Stanley, G. D. Lopaschuk, and J. G. McCormack, “Regulation of energy substrate metabolism in the diabetic heart,” Cardiovascular Research, vol. 34, no. 1, pp. 25–33, 1997. View at Publisher · View at Google Scholar · View at Scopus
  57. H. Taegtmeyer, P. McNulty, and M. E. Young, “Adaptation and maladaptation of the heart in diabetes: part I. General concepts,” Circulation, vol. 105, no. 14, pp. 1727–1733, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. B. Rodrigues, M. C. Cam, K. Jian, F. Lim, N. Sambandam, and G. Shepherd, “Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity,” Diabetes, vol. 46, no. 8, pp. 1346–1353, 1997. View at Google Scholar · View at Scopus
  59. K. Kobayashi, T. M. Forte, S. Taniguchi, B. Y. Ishida, K. Oka, and L. Chan, “The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of western diet feeding,” Metabolism, vol. 49, no. 1, pp. 22–31, 2000. View at Google Scholar · View at Scopus
  60. P. O'Looney, M. V. Maten, and G. V. Vahouny, “Insulin-mediated modifications of myocardial lipoprotein lipase and lipoprotein metabolism,” Journal of Biological Chemistry, vol. 258, no. 21, pp. 12994–13001, 1983. View at Google Scholar · View at Scopus
  61. T. Iwasaki, S. Takahashi, M. Takahashi et al., “Deficiency of the very low-density lipoprotein (VLDL) receptors in streptozotocin-induced diabetic rats: insulin dependency of the VLDL receptor,” Endocrinology, vol. 146, no. 8, pp. 3286–3294, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. Y. D. I. Chen, T. R. Risser, M. Cully, and G. M. Reaven, “Is the hypertriglyceridemia associated with insulin deficiency caused by decreased lipoprotein lipase activity?” Diabetes, vol. 28, no. 10, pp. 893–898, 1979. View at Google Scholar · View at Scopus
  63. G. Shepherd, M. C. Cam, N. Sambandam, M. A. Abrahani, and B. Rodrigues, “Streptozotocin-induced diabetes enhances cardiac heparin-releasable lipoprotein lipase activity in spontaneously hypertensive rats,” Hypertension, vol. 31, no. 3, pp. 878–884, 1998. View at Google Scholar · View at Scopus
  64. N. Sambandam, M. A. Abrahani, S. Craig, O. Al-Atar, E. Jeon, and B. Rodrigues, “Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts,” American Journal of Physiology, vol. 278, no. 6, pp. H1874–H1882, 2000. View at Google Scholar · View at Scopus
  65. R. H. Unger, G. O. Clark, P. E. Scherer, and L. Orci, “Lipid homeostasis, lipotoxicity and the metabolic syndrome,” Biochimica et Biophysica Acta, vol. 1801, no. 3, pp. 209–214, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. Y.-G. Niu and R. D. Evans, “Myocardial metabolism of triacylglycerol-rich lipoproteins in type 2 diabetes,” Journal of Physiology, vol. 587, no. 13, pp. 3301–3315, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. J. Castellano, J. Farre, J. Fernandes et al., “Hypoxia exacerbates Ca2+-handling disturbances induced by very low density lipoproteins (VLDL) in neonatal rat cardiomyocytes,” Journal of Molecular & Cellular Cardiology, vol. 50, no. 5, pp. 894–902, 2011. View at Publisher · View at Google Scholar
  68. B. Hennig and J. Dupont, “Lipoprotein lipid and protein responses to dietary fat and diabetes in rats,” Journal of Nutrition, vol. 113, no. 10, pp. 1984–1994, 1983. View at Google Scholar · View at Scopus
  69. D. A. Chappell and J. D. Medh, “Receptor-mediated mechanisms of lipoprotein remnant catabolism,” Progress in Lipid Research, vol. 37, no. 6, pp. 393–422, 1998. View at Publisher · View at Google Scholar · View at Scopus
  70. G. H. Tomkin and D. Owens, “Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis,” Diabetes/Metabolism Research and Reviews, vol. 17, no. 1, pp. 27–43, 2001. View at Publisher · View at Google Scholar · View at Scopus
  71. P. O'Looney, D. Irwin, P. Briscoe, and G. V. Vahouny, “Lipoprotein composition as a component in the lipoprotein clearance defect in experimental diabetes,” Journal of Biological Chemistry, vol. 260, no. 1, pp. 428–432, 1985. View at Google Scholar · View at Scopus
  72. E. R. Christ, P. V. Carroll, E. Albany et al., “Normal VLDL metabolism despite altered lipoprotein composition in type 1 diabetes mellitus,” Clinical Endocrinology, vol. 55, no. 6, pp. 777–787, 2001. View at Publisher · View at Google Scholar · View at Scopus
  73. S. Ishibashi, N. Yamada, H. Shimano, F. Takaku, Y. Akanuma, and T. Murase, “Composition of very-low-density lipoproteins in non-insulin-dependent diabetes mellitus,” Clinical Chemistry, vol. 35, no. 5, pp. 808–812, 1989. View at Google Scholar · View at Scopus
  74. A. Rivellese, G. Riccardi, G. Romano et al., “Presence of very low density lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients; effects of blood glucose optimisation,” Diabetologia, vol. 31, no. 12, pp. 884–888, 1988. View at Google Scholar · View at Scopus
  75. T. J. Kalogeris and J. A. Story, “Lymph chylomicron composition and size are modified by level of intestinally infused cholesterol and triglyceride source in rats,” Journal of Nutrition, vol. 122, no. 5, pp. 1045–1055, 1992. View at Google Scholar · View at Scopus
  76. B. V. Howard, “Lipoprotein metabolism in diabetes,” Current Opinion in Lipidology, vol. 5, no. 3, pp. 216–220, 1994. View at Google Scholar · View at Scopus
  77. J. Björkegren, M. Véniant, S. K. Kim et al., “Lipoprotein secretion and triglyceride stores in the heart,” Journal of Biological Chemistry, vol. 276, no. 42, pp. 38511–38517, 2001. View at Publisher · View at Google Scholar · View at Scopus
  78. Y. A. Carpentier and O. Scruel, “Changes in the concentration and composition of plasma lipoproteins during the acute phase response,” Current Opinion in Clinical Nutrition & Metabolic Care, vol. 5, no. 2, pp. 153–158, 2002. View at Google Scholar · View at Scopus
  79. S. Lanza-Jacoby, S. H. Wong, A. Tabares, D. Baer, and T. Schneider, “Disturbances in the composition of plasma lipoproteins during gram-negative sepsis in the rat,” Biochimica et Biophysica Acta, vol. 1124, no. 3, pp. 233–240, 1992. View at Publisher · View at Google Scholar · View at Scopus
  80. L. Jia, M. Takahashi, H. Morimoto et al., “Changes in cardiac lipid metabolism during sepsis: the essential role of very low-density lipoprotein receptors,” Cardiovascular Research, vol. 69, no. 2, pp. 545–555, 2006. View at Publisher · View at Google Scholar · View at Scopus
  81. J. F. P. Berbée, L. M. Havekes, and P. C. N. Rensen, “Apolipoproteins modulate the inflammatory response to lipopolysaccharide,” Journal of Endotoxin Research, vol. 11, no. 2, pp. 97–103, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. A. M. Barcia and H. W. Harris, “Triglyceride-rich lipoproteins as agents of innate immunity,” Clinical Infectious Diseases, vol. 41, supplement 7, pp. S498–S503, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. P. R. L. de Vasconcelos, M. G. W. Kettlewell, G. F. Gibbons, and D. H. Williamson, “Increased rates of hepatic cholesterogenesis and fatty acid synthesis in septic rats in vivo: evidence for the possible involvement of insulin,” Clinical Science, vol. 76, no. 2, pp. 205–211, 1989. View at Google Scholar · View at Scopus
  84. N. Bartolomé, B. Arteta, M. J. Martínez, Y. Chico, and B. Ochoa, “Kupffer cell products and interleukin 1β directly promote VLDL secretion and apoB mRNA up-regulation in rodent hepatocytes,” Innate Immunity, vol. 14, no. 4, pp. 255–266, 2008. View at Publisher · View at Google Scholar
  85. R. J. Tripp, A. Tabares, H. Wang, and S. Lanza-Jacoby, “Altered hepatic production of apolipoproteins B and E in the fasted septic rat: factors in the development of hypertriglyceridemia,” Journal of Surgical Research, vol. 55, no. 5, pp. 465–472, 1993. View at Publisher · View at Google Scholar · View at Scopus
  86. H. W. Phetteplace, N. Sedkova, K. I. Hirano, N. O. Davidson, and S. P. Lanza-Jacoby, “Escherichia coli sepsis increases hepatic apolipoprotein B secretion by inhibiting degradation,” Lipids, vol. 35, no. 10, pp. 1079–1085, 2000. View at Google Scholar · View at Scopus
  87. E. P. Reaven and G. M. Reaven, “Mechanisms for development of diabetic hypertriglyceridemia in streptozotocin treated rats. Effect of diet and duration of insulin deficiency,” Journal of Clinical Investigation, vol. 54, no. 5, pp. 1167–1178, 1974. View at Google Scholar · View at Scopus
  88. S. Han, C. P. Liang, M. Westerterp et al., “Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice,” Journal of Clinical Investigation, vol. 119, no. 4, pp. 1029–1041, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. G. F. Gibbons, A. M. Brown, D. Wiggins, and R. Pease, “The roles of insulin and fatty acids in the regulation of hepatic very-low-density lipoprotein assembly,” Journal of the Royal Society of Medicine, vol. 95, supplement 42, pp. 23–32, 2002. View at Google Scholar